What pregnancy category is clonazepam in the U.S.?
Clonazepam is a benzodiazepine. The traditional U.S. pregnancy “category” system (A, B, C, D, X) has largely been phased out by the FDA in favor of the PLL (Pregnancy and Lactation Labeling) system. Under that older framework, clonazepam was typically listed as Category C—meaning risk to the fetus cannot be ruled out and the drug should be used only if the potential benefit justifies the potential risk.
How does the older “Category C” labeling affect decision-making?
With Category C, clinicians generally weigh:
- Whether the medication is necessary to control a condition (for example, seizures or severe anxiety)
- The severity of stopping it abruptly (which can worsen the underlying disease and may be medically dangerous)
- Alternatives that may have different risk profiles for pregnancy
What do people usually worry about with clonazepam use in pregnancy?
Common patient concerns include effects on the developing fetus and newborn, especially with exposure later in pregnancy. Benzodiazepines are sometimes associated with:
- Higher chance of neonatal sedation or breathing problems when exposure occurs near delivery
- Withdrawal or floppy-infant–type symptoms in newborns after late-pregnancy exposure
Is clonazepam safer than other benzodiazepines in pregnancy?
The provided information doesn’t include head-to-head pregnancy risk comparisons across benzodiazepines. If you’re trying to compare clonazepam with alternatives, the key practical question to ask your clinician is whether your specific indication (seizures vs anxiety), dose, and timing during pregnancy change the risk-benefit balance.
Should clonazepam be stopped during pregnancy?
Do not stop clonazepam suddenly without prescriber guidance. Abrupt discontinuation can cause withdrawal and can worsen the condition it treats (for example, provoking seizures). Any change in treatment in pregnancy is usually done by tapering or switching under medical supervision.
What about breastfeeding?
The older category label does not directly predict breastfeeding safety. For clonazepam, clinicians often consider infant sedation risk, timing of doses, and the infant’s age and health, especially if the infant is premature or medically fragile.
If you tell me how many weeks pregnant you are (or whether you’re asking about breastfeeding), and the reason clonazepam is prescribed (seizures, anxiety, panic, etc.), I can tailor the risk considerations more closely to that situation.